Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Market Cap : $0.00 Mil (As of Apr. 28, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Caliber Imaging & Diagnostics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Caliber Imaging & Diagnostics's share price for the quarter that ended in Mar. 2014 was $0.65. Caliber Imaging & Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2014 was 8.51 Mil. Therefore, Caliber Imaging & Diagnostics's market cap for the quarter that ended in Mar. 2014 was $5.53 Mil.

Caliber Imaging & Diagnostics's quarterly market cap declined from Sep. 2013 ($7.66 Mil) to Dec. 2013 ($4.68 Mil) but then increased from Dec. 2013 ($4.68 Mil) to Mar. 2014 ($5.53 Mil).

Caliber Imaging & Diagnostics's annual market cap increased from Dec. 2011 ($0.00 Mil) to Dec. 2012 ($12.76 Mil) but then declined from Dec. 2012 ($12.76 Mil) to Dec. 2013 ($4.68 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Caliber Imaging & Diagnostics's Enterprise Value for Today is $0.00 Mil.

Caliber Imaging & Diagnostics Market Cap Historical Data

The historical data trend for Caliber Imaging & Diagnostics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliber Imaging & Diagnostics Market Cap Chart

Caliber Imaging & Diagnostics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Market Cap

12.76

4.68

Caliber Imaging & Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14
Market Cap	Get a 7-Day Free Trial													10.63	10.21	7.66	4.68	5.53

Competitive Comparison of Caliber Imaging & Diagnostics's Market Cap

For the Medical Devices subindustry, Caliber Imaging & Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caliber Imaging & Diagnostics's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Caliber Imaging & Diagnostics's Market Cap distribution charts can be found below:

* The bar in red indicates where Caliber Imaging & Diagnostics's Market Cap falls into.

Caliber Imaging & Diagnostics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Caliber Imaging & Diagnostics's Market Cap for the fiscal year that ended in Dec. 2013 is calculated as

Market Cap (A: Dec. 2013 )	=	Share Price (A: Dec. 2013 )	*	Shares Outstanding (EOP) (A: Dec. 2013 )
	=	$0.55	*	8.50737
	=	$4.68

Caliber Imaging & Diagnostics's Market Cap for the quarter that ended in Mar. 2014 is calculated as

Market Cap (Q: Mar. 2014 )	=	Share Price (Q: Mar. 2014 )	*	Shares Outstanding (EOP) (Q: Mar. 2014 )
	=	$0.65	*	8.50737
	=	$5.53

Caliber Imaging & Diagnostics (OTCPK:LCDX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Caliber Imaging & Diagnostics Market Cap Related Terms

Thank you for viewing the detailed overview of Caliber Imaging & Diagnostics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Caliber Imaging & Diagnostics Inc (OTCPK:LCDX) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Burtt Road, Suite 203, Andover, MA, USA, 01810

Website

http://www.caliberid.com

Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.

Executives

Paul Stuka	director	C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
William J Shea	director, 10 percent owner	11825 N PENNSYLVANIA ST, CARMEL IN 46032
Kevin M Cronin	director
Richard Christopher	officer: Chief Financial Officer	C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
Martin Joseph Joyce	officer: Chief Financial Officer	1050 HINGHAM STREET, ROCKLAND MA 02370
Matthew S Cox	director	58 OAKWOOD DRIVE, CHAPEL HILL NC 27517

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Headlines

From GuruFocus

Caliber Imaging & Diagnostics, Formerly Lucid, Inc. (LCDX), Has No Relation To Lucid Motors

By PRNewswire PRNewswire • 08-25-2020